{"id":3371,"date":"2026-09-02T09:05:59","date_gmt":"2026-09-02T08:05:59","guid":{"rendered":"https:\/\/seamlessbio.de\/?p=3371"},"modified":"2026-09-02T09:06:02","modified_gmt":"2026-09-02T08:06:02","slug":"hek293t-serum-free-adaptation-simplacex","status":"publish","type":"post","link":"https:\/\/seamlessbio.de\/de\/hek293t-serum-free-adaptation-simplacex\/","title":{"rendered":"HEK293T Serum-Free Adaptation Protocol"},"content":{"rendered":"<p><!--\nWORDPRESS BLOG POST\nSlug: hek293t-serum-free-adaptation-simplacex\nSEO Title: HEK293T Serum-Free Adaptation Protocol \u2014 SimplaceX & SimplaceCDX | SeamlessBio\nMeta Description: Step-by-step protocol for adapting HEK293T cells to serum-free medium using SimplaceX and SimplaceCDX \u2014 including the suspension cell rescue step most protocols miss.\nFocus Keyword: HEK293T serum-free adaptation protocol SimplaceX\nAdditional Keywords: HEK293T serum-free medium adaptation, SimplaceX HEK293T protocol, serum-free HEK293T AAV production, chemically defined HEK293T medium SimplaceCDX\nCategory: Cell Culture \u00b7 AAV & Viral Vectors \u00b7 Protocols\nTags: HEK293T, serum-free, SimplaceX, SimplaceCDX, AAV, adaptation protocol\n--><\/p>\n<style>\n.sb-bp{font-family:-apple-system,BlinkMacSystemFont,\"Segoe UI\",Roboto,sans-serif;max-width:780px;margin:0 auto;padding:0 0 60px;color:#202020;line-height:1.75}\n.sb-bp .lede{font-size:18px;font-weight:500;color:#3a4a50;border-left:4px solid #18b7b2;padding-left:20px;margin:0 0 32px;line-height:1.65}\n.sb-bp h2{font-size:24px;font-weight:800;margin:44px 0 14px;color:#111;padding-bottom:10px;border-bottom:2px solid #e2eceb}\n.sb-bp h3{font-size:18px;font-weight:700;margin:32px 0 10px;color:#18b7b2}\n.sb-bp p{margin:0 0 18px}\n.sb-bp ul,.sb-bp ol{margin:0 0 18px;padding-left:24px}\n.sb-bp li{margin-bottom:8px}\n.sb-bp table{width:100%;border-collapse:collapse;font-size:14px;margin:20px 0 28px;display:block;overflow-x:auto}\n.sb-bp th{background:#18b7b2;color:#fff;text-align:left;padding:10px 14px;font-weight:700;white-space:nowrap}\n.sb-bp td{padding:10px 14px;border-bottom:1px solid #e2eceb;vertical-align:top}\n.sb-bp tr:last-child td{border-bottom:none}\n.sb-bp td:first-child{font-weight:600;color:#111}\n.sb-bp a{color:#18b7b2;text-decoration:none;font-weight:600}\n.sb-bp strong{color:#111}\n.sb-bp .box{background:#f1faf9;border-left:4px solid #18b7b2;border-radius:0 12px 12px 0;padding:20px 24px;margin:28px 0}\n.sb-bp .warn{background:#fff8e1;border-left:4px solid #f59e0b;border-radius:0 12px 12px 0;padding:20px 24px;margin:28px 0}\n.sb-bp .step{background:#fff;border:1.5px solid #daf3f2;border-radius:14px;padding:20px 24px;margin-bottom:16px;display:grid;grid-template-columns:48px 1fr;gap:16px;align-items:start}\n.sb-bp .step-n{background:#18b7b2;color:#fff;font-size:18px;font-weight:900;border-radius:50%;width:40px;height:40px;display:flex;align-items:center;justify-content:center;flex-shrink:0;margin-top:2px}\n.sb-bp .step-body h3{margin:0 0 8px;font-size:16px;color:#111}\n.sb-bp .step-body p{margin:0 0 8px;font-size:14px}\n.sb-bp .step-body ul{margin:0;font-size:14px}\n.sb-bp .product-box{background:#f1faf9;border:1.5px solid #daf3f2;border-radius:14px;padding:20px 24px;margin:28px 0}\n.sb-bp .product-box h3{font-size:15px;font-weight:700;color:#18b7b2;margin:0 0 10px}\n.sb-bp .product-box table{margin:0;font-size:13px}\n.sb-bp .cta-box{background:linear-gradient(135deg,#e4f6f5,#f4fbfb);border:1px solid rgba(24,183,178,.2);border-radius:16px;padding:28px;margin-top:44px;text-align:center}\n.sb-bp .cta-box h3{color:#111;margin:0 0 10px;font-size:20px}\n.sb-bp .cta-box p{color:#5b6b71;margin:0 0 18px}\n.sb-bp .cta-btns{display:flex;justify-content:center;gap:12px;flex-wrap:wrap}\n.sb-bp .btn{display:inline-block;background:#18b7b2;color:#fff!important;padding:10px 22px;border-radius:8px;font-weight:700;font-size:14px;text-decoration:none!important}\n.sb-bp .btn-o{display:inline-block;border:2px solid #18b7b2;color:#18b7b2!important;padding:8px 22px;border-radius:8px;font-weight:700;font-size:14px;text-decoration:none!important}\n<\/style>\n<div class=\"sb-bp\">\n<p class=\"lede\">HEK293T cells adapt to serum-free medium more readily than most mammalian cell lines \u2014 but the adaptation process has one critical failure point that most protocols ignore: the suspension cells that detach during the early adaptation phase. This protocol covers the complete adaptation procedure using SimplaceX and SimplaceCDX, including how to rescue and reintegrate suspension cells instead of discarding them.<\/p>\n<h2>Which medium to use \u2014 SimplaceX vs SimplaceCDX<\/h2>\n<div class=\"product-box\">\n<h3>Available formats \u2014 500 mL and 2,000 mL<\/h3>\n<table>\n<thead>\n<tr>\n<th>Produkt<\/th>\n<th>Type<\/th>\n<th>When to use<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>SimplaceX<\/td>\n<td>Serum-free, protein-supplemented<\/td>\n<td>Standard adaptation, research-grade and pre-clinical AAV production \u2014 easier adaptation, faster recovery of growth rate<\/td>\n<\/tr>\n<tr>\n<td>SimplaceCDX<\/td>\n<td>Chemically defined \u2014 no animal-derived or recombinant protein components<\/td>\n<td>IND-enabling and clinical-grade AAV production where fully chemically defined medium is required for GMP documentation \u2014 slightly more demanding adaptation<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>For most research and pre-clinical AAV production, start with SimplaceX. Transition to SimplaceCDX once SimplaceX adaptation is complete if chemically defined medium is required for your regulatory pathway.<\/p>\n<h2>The suspension cell problem \u2014 and why it matters<\/h2>\n<p>HEK293T cells are loosely adherent under standard culture conditions. During serum-free adaptation, the loss of adhesion-promoting serum proteins (fibronectin, vitronectin, and albumin in FBS) causes an increase in spontaneous detachment \u2014 cells that would have remained adherent in FBS-containing medium now enter suspension. Most protocols advise discarding the medium (and with it, the suspended cells) at each passage during adaptation. This is a mistake.<\/p>\n<p>Suspended HEK293T cells during serum-free adaptation are not dead \u2014 they are simply detached. If discarded repeatedly, you are applying negative selection pressure for adherence at the cost of overall cell number and culture recovery rate. Instead, suspended cells should be rescued at every passage and reintegrated into the adherent culture.<\/p>\n<div class=\"warn\">\n<strong>Critical rule:<\/strong> During the entire adaptation period, never discard the medium without first centrifuging it to recover suspension cells. This single step determines whether adaptation takes 5 passages or 15.\n<\/div>\n<h2>Step-by-step adaptation protocol<\/h2>\n<div class=\"step\">\n<div class=\"step-n\">1<\/div>\n<div class=\"step-body\">\n<h3>Starting conditions<\/h3>\n<p>Begin with low-passage HEK293T cells (&lt;25 passages) in standard DMEM + 10% FBS. Cells should be actively proliferating with doubling time \u226420h and &gt;95% viability. Do not start adaptation from cells that have been under stress, over-confluent, or recently thawed from a poorly characterised vial.<\/p>\n<ul>\n<li>Confirm doubling time and viability before starting<\/li>\n<li>Use a T75 or T175 flask for the adaptation \u2014 not a large cell stack<\/li>\n<li>Record the passage number at the start of adaptation<\/li>\n<\/ul><\/div>\n<\/div>\n<div class=\"step\">\n<div class=\"step-n\">2<\/div>\n<div class=\"step-body\">\n<h3>Passages 1\u20133 \u2014 Gradual FBS reduction with SimplaceX<\/h3>\n<p>Replace standard DMEM + 10% FBS with the following transition medium sequence:<\/p>\n<table>\n<thead>\n<tr>\n<th>Passage<\/th>\n<th>Medium composition<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Passage 1<\/td>\n<td>DMEM + 1% FBS + 1\u00d7 SimplaceX (full volume)<\/td>\n<\/tr>\n<tr>\n<td>Passage 2<\/td>\n<td>DMEM + 0.5% FBS + 1\u00d7 SimplaceX<\/td>\n<\/tr>\n<tr>\n<td>Passage 3<\/td>\n<td>DMEM + 0.5% FBS + 1\u00d7 SimplaceX<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The 0.5\u20131% FBS in the first 1\u20133 passages slows the adaptation rate deliberately \u2014 this reduces the metabolic stress of the transition and produces a more stable adapted population. Do not skip directly to 0% FBS.<\/p>\n<\/p><\/div>\n<\/div>\n<div class=\"step\">\n<div class=\"step-n\">3<\/div>\n<div class=\"step-body\">\n<h3>Passages 4\u20136 \u2014 Fully serum-free SimplaceX<\/h3>\n<p>Switch to DMEM + 1\u00d7 SimplaceX with no FBS. This is the critical phase \u2014 detachment will increase during these passages.<\/p>\n<p><strong>At every medium change and passage, follow the suspension cell rescue protocol:<\/strong><\/p>\n<ul>\n<li>Collect the conditioned medium from the flask into a 50 mL tube<\/li>\n<li>Centrifuge at 300 \u00d7 g for 5 minutes<\/li>\n<li>Discard the supernatant<\/li>\n<li>Resuspend the cell pellet in fresh DMEM + 1\u00d7 SimplaceX<\/li>\n<li>Return the resuspended suspension cells to the flask together with the trypsinised adherent cells<\/li>\n<\/ul>\n<p>Monitor doubling time at each passage \u2014 expect 25\u201340h during this phase (slower than FBS baseline of 18\u201320h). This is normal.<\/p>\n<\/p><\/div>\n<\/div>\n<div class=\"step\">\n<div class=\"step-n\">4<\/div>\n<div class=\"step-body\">\n<h3>Cell detachment \u2014 serum-free trypsinisation<\/h3>\n<p>In serum-free conditions, standard trypsin neutralisation with FBS is not available. Use one of these approaches:<\/p>\n<ul>\n<li><strong>Option A (preferred):<\/strong> PBS + 5 mM EDTA \u2014 pipette gently over the cell layer for 3\u20135 minutes at 37\u00b0C. HEK293T cells detach without trypsin in EDTA-PBS in serum-free conditions. No enzyme inactivation step needed.<\/li>\n<li><strong>Option B:<\/strong> Standard 0.05% Trypsin-EDTA \u2014 but centrifuge immediately at 300 \u00d7 g for 5 min to pellet cells, aspirate all trypsin-containing supernatant, and resuspend in fresh SimplaceX. Do not allow trypsin contact beyond 3 minutes.<\/li>\n<\/ul>\n<div class=\"box\" style=\"margin-top:12px;\">\n      <strong>Why trypsin removal is critical in serum-free:<\/strong> In standard culture, FBS in the quenching medium rapidly inactivates residual trypsin by protease inhibitors (\u03b12-macroglobulin, \u03b11-antitrypsin). In serum-free medium, there are no protease inhibitors \u2014 residual trypsin continues to cleave cell surface proteins, damaging adhesion receptors and reducing re-attachment efficiency. Complete centrifugation removal of trypsin is the only reliable inactivation method in serum-free conditions.\n    <\/div>\n<\/p><\/div>\n<\/div>\n<div class=\"step\">\n<div class=\"step-n\">5<\/div>\n<div class=\"step-body\">\n<h3>Passages 7\u201310 \u2014 Growth rate recovery<\/h3>\n<p>After 3\u20135 fully serum-free passages, cells should be adapted \u2014 meaning they proliferate consistently in SimplaceX without FBS. However, growth rate at this stage will still be 20\u201340% slower than the FBS baseline. This is expected and does not indicate a problem.<\/p>\n<p>Growth rate recovery occurs over the next 5\u201320 passages as the cell population selects for individuals with the highest fitness in serum-free conditions. Continue applying the suspension cell rescue protocol at every passage \u2014 the rescued cells include those most adapted to suspension conditions and should not be discarded.<\/p>\n<table>\n<thead>\n<tr>\n<th>Phase<\/th>\n<th>Expected doubling time<\/th>\n<th>Action<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Passages 1\u20133 (FBS reduction)<\/td>\n<td>20\u201326h<\/td>\n<td>Normal \u2014 continue protocol<\/td>\n<\/tr>\n<tr>\n<td>Passages 4\u20136 (first serum-free)<\/td>\n<td>28\u201342h<\/td>\n<td>Normal \u2014 rescue suspension cells every passage<\/td>\n<\/tr>\n<tr>\n<td>Passages 7\u201310 (early adapted)<\/td>\n<td>22\u201332h<\/td>\n<td>Improving \u2014 continue rescue protocol<\/td>\n<\/tr>\n<tr>\n<td>Passages 11\u201325 (fully adapted)<\/td>\n<td>18\u201324h<\/td>\n<td>Equivalent to FBS baseline \u2014 adaptation complete<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<\/div>\n<div class=\"step\">\n<div class=\"step-n\">6<\/div>\n<div class=\"step-body\">\n<h3>Transition to SimplaceCDX (if required)<\/h3>\n<p>If fully chemically defined medium (SimplaceCDX) is required for your GMP or regulatory pathway, begin the SimplaceX \u2192 SimplaceCDX transition only after cells are fully adapted to SimplaceX (stable doubling time \u226422h for at least 3 consecutive passages).<\/p>\n<p>Transition protocol SimplaceX \u2192 SimplaceCDX:<\/p>\n<ul>\n<li>Passage 1: 75% SimplaceX + 25% SimplaceCDX<\/li>\n<li>Passage 2: 50% SimplaceX + 50% SimplaceCDX<\/li>\n<li>Passage 3: 25% SimplaceX + 75% SimplaceCDX<\/li>\n<li>Passage 4+: 100% SimplaceCDX<\/li>\n<\/ul>\n<p>Apply the suspension cell rescue protocol throughout this second transition phase as well.<\/p>\n<\/p><\/div>\n<\/div>\n<div class=\"step\">\n<div class=\"step-n\">7<\/div>\n<div class=\"step-body\">\n<h3>AAV production test \u2014 confirm equivalence before scale-up<\/h3>\n<p>Once cells show stable doubling time in SimplaceX or SimplaceCDX for at least 3 consecutive passages, run a small-scale AAV production test (one 15 cm dish, triple transfection) to confirm titre equivalence with your FBS baseline before scaling up production.<\/p>\n<ul>\n<li>Use the same plasmid preparation, PEI batch, and protocol as your FBS reference run<\/li>\n<li>Measure physical titre by qPCR and compare to FBS reference<\/li>\n<li>Accept if titre is within 2\u00d7 of FBS reference \u2014 most fully adapted HEK293T in SimplaceX will reach within 1.5\u00d7 of FBS titre<\/li>\n<li>If titre is &gt;2\u00d7 below FBS reference, continue adaptation for 3\u20135 more passages and re-test<\/li>\n<\/ul><\/div>\n<\/div>\n<h2>Troubleshooting<\/h2>\n<table>\n<thead>\n<tr>\n<th>Problem<\/th>\n<th>Wahrscheinlichste Ursache<\/th>\n<th>L\u00f6sung<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Cells not re-attaching after passage<\/td>\n<td>Residual trypsin, or cells too stressed<\/td>\n<td>Switch to PBS + 5 mM EDTA for detachment \u2014 eliminate trypsin entirely<\/td>\n<\/tr>\n<tr>\n<td>Doubling time not recovering after passage 10<\/td>\n<td>Suspension cells discarded during adaptation \u2014 population not selected for serum-free fitness<\/td>\n<td>Restart adaptation from a freshly thawed low-passage vial, apply rescue protocol rigorously from passage 1<\/td>\n<\/tr>\n<tr>\n<td>Very high suspension cell fraction (&gt;50% of cells in suspension)<\/td>\n<td>Normal during passages 4\u20136 \u2014 do not discard<\/td>\n<td>Rescue all suspension cells at every passage \u2014 this is the protocol working correctly<\/td>\n<\/tr>\n<tr>\n<td>AAV titre &gt;2\u00d7 below FBS reference after full adaptation<\/td>\n<td>Cells adapted but not yet optimised for production<\/td>\n<td>Continue for 5\u201310 more passages before re-testing \u2014 full growth rate recovery takes up to 20 passages<\/td>\n<\/tr>\n<tr>\n<td>Cell clumping in suspension<\/td>\n<td>EDTA depletion or calcium\/magnesium in PBS<\/td>\n<td>Confirm PBS is calcium- and magnesium-free (PBS \u2212\/\u2212); add 5 mM EDTA if not already present<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Key points \u2014 summary<\/h2>\n<ul>\n<li>Start with 0.5\u20131% FBS in SimplaceX for passages 1\u20133 \u2014 slower adaptation is more stable adaptation<\/li>\n<li><strong>Never discard suspension cells<\/strong> \u2014 centrifuge, resuspend in fresh medium, and return to the flask at every passage<\/li>\n<li>Use PBS + 5 mM EDTA instead of trypsin wherever possible in serum-free conditions<\/li>\n<li>If trypsin is used, centrifuge and remove completely before resuspending \u2014 no FBS to inactivate residual trypsin<\/li>\n<li>Doubling time recovers over 5\u201320 passages after full serum-free adaptation \u2014 slower early growth is normal and expected<\/li>\n<li>Run a small-scale AAV production test before committing to full-scale serum-free production<\/li>\n<li>Transition to SimplaceCDX only after full SimplaceX adaptation is confirmed<\/li>\n<\/ul>\n<div class=\"cta-box\">\n<h3>SimplaceX &amp; SimplaceCDX \u2014 Serum-Free Medium for HEK293T AAV Production<\/h3>\n<p>Available in 500 mL and 2,000 mL. Data sheet included. Request a sample for adaptation testing before committing to large-volume purchase.<\/p>\n<div class=\"cta-btns\">\n    <a href=\"https:\/\/seamlessbio.de\/de\/kontakt\/\" class=\"btn\">Request Sample or Quote<\/a><br \/>\n    <a href=\"https:\/\/seamlessbio.de\/de\/ressourcen\/blog\/serum-free-medium-aav-production-complete-recipe\/\" class=\"btn-o\">Serum-Free Medium Components Guide<\/a><br \/>\n    <a href=\"https:\/\/seamlessbio.de\/de\/ressourcen\/blog\/fbs-vs-serum-free-aav-production-when-to-switch\/\" class=\"btn-o\">FBS vs Serum-Free \u2014 When to Switch<\/a><br \/>\n    <a href=\"https:\/\/seamlessbio.de\/de\/ressourcen\/blog\/hek293t-confluency-aav-transfection-yield\/\" class=\"btn-o\">HEK293T Confluency Guide<\/a>\n  <\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>HEK293T cells adapt to serum-free medium more readily than most mammalian cell lines \u2014 but the adaptation process has one critical failure point that most protocols ignore: the suspension cells [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[46],"tags":[],"class_list":["post-3371","post","type-post","status-publish","format-standard","hentry","category-cell-culture"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>HEK293T Serum-Free Adaptation Protocol \u2014 SimplaceX &amp; SimplaceCDX | SeamlessBio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/seamlessbio.de\/de\/hek293t-serum-free-adaptation-simplacex\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HEK293T Serum-Free Adaptation Protocol \u2014 SimplaceX &amp; SimplaceCDX | SeamlessBio\" \/>\n<meta property=\"og:description\" content=\"HEK293T cells adapt to serum-free medium more readily than most mammalian cell lines \u2014 but the adaptation process has one critical failure point that most protocols ignore: the suspension cells [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/seamlessbio.de\/de\/hek293t-serum-free-adaptation-simplacex\/\" \/>\n<meta property=\"og:site_name\" content=\"SeamlessBio\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-02T08:05:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-02T08:06:02+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"6\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/person\\\/cd959a5b0b21c02c26d6ffef79f0d529\"},\"headline\":\"HEK293T Serum-Free Adaptation Protocol\",\"datePublished\":\"2026-09-02T08:05:59+00:00\",\"dateModified\":\"2026-09-02T08:06:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/\"},\"wordCount\":1280,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"articleSection\":[\"Cell Culture\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/\",\"name\":\"HEK293T Serum-Free Adaptation Protocol \u2014 SimplaceX & SimplaceCDX | SeamlessBio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\"},\"datePublished\":\"2026-09-02T08:05:59+00:00\",\"dateModified\":\"2026-09-02T08:06:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#website\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"name\":\"SeamlessBio\",\"description\":\"Expert for biological materials for pharma, vaccines and research organizations\",\"publisher\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/seamlessbio.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":[\"Organization\",\"Place\",\"ProfessionalService\"],\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#organization\",\"name\":\"SeamlessBio\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/\",\"logo\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/#local-main-organization-logo\"},\"image\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/#local-main-organization-logo\"},\"address\":{\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/#local-main-place-address\"},\"telephone\":[\"+49 (851) 37932226\"],\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+49 (851) 37932226\",\"email\":\"info@seamlessbio.de\"},\"openingHoursSpecification\":[{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Monday\",\"Tuesday\",\"Wednesday\",\"Thursday\",\"Friday\"],\"opens\":\"09:00\",\"closes\":\"17:00\"},{\"@type\":\"OpeningHoursSpecification\",\"dayOfWeek\":[\"Saturday\",\"Sunday\"],\"opens\":\"00:00\",\"closes\":\"00:00\"}],\"email\":\"info@seamlessbio.de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/#\\\/schema\\\/person\\\/cd959a5b0b21c02c26d6ffef79f0d529\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"http:\\\/\\\/seamlessbio.de\"],\"url\":\"https:\\\/\\\/seamlessbio.de\\\/de\\\/author\\\/admin\\\/\"},{\"@type\":\"PostalAddress\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/#local-main-place-address\",\"streetAddress\":\"Dr.-Ernst-Derra-Str. 4\",\"addressLocality\":\"Passau\",\"postalCode\":\"94036\",\"addressRegion\":\"Bavaria\",\"addressCountry\":\"DE\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/seamlessbio.de\\\/hek293t-serum-free-adaptation-simplacex\\\/#local-main-organization-logo\",\"url\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/134428046-2.png\",\"contentUrl\":\"https:\\\/\\\/seamlessbio.de\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/134428046-2.png\",\"width\":973,\"height\":288,\"caption\":\"SeamlessBio\"}]}<\/script>\n<meta name=\"geo.placename\" content=\"Passau\" \/>\n<meta name=\"geo.region\" content=\"Deutschland\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HEK293T Serum-Free Adaptation Protocol \u2014 SimplaceX & SimplaceCDX | SeamlessBio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/seamlessbio.de\/de\/hek293t-serum-free-adaptation-simplacex\/","og_locale":"de_DE","og_type":"article","og_title":"HEK293T Serum-Free Adaptation Protocol \u2014 SimplaceX & SimplaceCDX | SeamlessBio","og_description":"HEK293T cells adapt to serum-free medium more readily than most mammalian cell lines \u2014 but the adaptation process has one critical failure point that most protocols ignore: the suspension cells [&hellip;]","og_url":"https:\/\/seamlessbio.de\/de\/hek293t-serum-free-adaptation-simplacex\/","og_site_name":"SeamlessBio","article_published_time":"2026-09-02T08:05:59+00:00","article_modified_time":"2026-09-02T08:06:02+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"admin","Gesch\u00e4tzte Lesezeit":"6\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/#article","isPartOf":{"@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/"},"author":{"name":"admin","@id":"https:\/\/seamlessbio.de\/#\/schema\/person\/cd959a5b0b21c02c26d6ffef79f0d529"},"headline":"HEK293T Serum-Free Adaptation Protocol","datePublished":"2026-09-02T08:05:59+00:00","dateModified":"2026-09-02T08:06:02+00:00","mainEntityOfPage":{"@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/"},"wordCount":1280,"commentCount":0,"publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"articleSection":["Cell Culture"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/","url":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/","name":"HEK293T Serum-Free Adaptation Protocol \u2014 SimplaceX & SimplaceCDX | SeamlessBio","isPartOf":{"@id":"https:\/\/seamlessbio.de\/#website"},"datePublished":"2026-09-02T08:05:59+00:00","dateModified":"2026-09-02T08:06:02+00:00","breadcrumb":{"@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/"]}]},{"@type":"WebSite","@id":"https:\/\/seamlessbio.de\/#website","url":"https:\/\/seamlessbio.de\/","name":"SeamlessBio","description":"Experte f\u00fcr biologische Materialien f\u00fcr die Pharmaindustrie, Impfstoffe und Forschungseinrichtungen","publisher":{"@id":"https:\/\/seamlessbio.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/seamlessbio.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":["Organization","Place","ProfessionalService"],"@id":"https:\/\/seamlessbio.de\/#organization","name":"SeamlessBio","url":"https:\/\/seamlessbio.de\/","logo":{"@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/#local-main-organization-logo"},"image":{"@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/#local-main-organization-logo"},"address":{"@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/#local-main-place-address"},"telephone":["+49 (851) 37932226"],"contactPoint":{"@type":"ContactPoint","telephone":"+49 (851) 37932226","email":"info@seamlessbio.de"},"openingHoursSpecification":[{"@type":"OpeningHoursSpecification","dayOfWeek":["Monday","Tuesday","Wednesday","Thursday","Friday"],"opens":"09:00","closes":"17:00"},{"@type":"OpeningHoursSpecification","dayOfWeek":["Saturday","Sunday"],"opens":"00:00","closes":"00:00"}],"email":"info@seamlessbio.de"},{"@type":"Person","@id":"https:\/\/seamlessbio.de\/#\/schema\/person\/cd959a5b0b21c02c26d6ffef79f0d529","name":"admin","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c82349c4c3fd3df1cfbb69d5f386d959a89ab4c9dcec1e7889a5140df2c0f1a0?s=96&d=mm&r=g","caption":"admin"},"sameAs":["http:\/\/seamlessbio.de"],"url":"https:\/\/seamlessbio.de\/de\/author\/admin\/"},{"@type":"PostalAddress","@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/#local-main-place-address","streetAddress":"Dr.-Ernst-Derra-Str. 4","addressLocality":"Passau","postalCode":"94036","addressRegion":"Bavaria","addressCountry":"DE"},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/seamlessbio.de\/hek293t-serum-free-adaptation-simplacex\/#local-main-organization-logo","url":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046-2.png","contentUrl":"https:\/\/seamlessbio.de\/wp-content\/uploads\/2026\/04\/134428046-2.png","width":973,"height":288,"caption":"SeamlessBio"}]},"geo.placename":"Passau","geo.region":"Deutschland"},"_links":{"self":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/3371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/comments?post=3371"}],"version-history":[{"count":1,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/3371\/revisions"}],"predecessor-version":[{"id":3372,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/posts\/3371\/revisions\/3372"}],"wp:attachment":[{"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/media?parent=3371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/categories?post=3371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/seamlessbio.de\/de\/wp-json\/wp\/v2\/tags?post=3371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}